These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37338608)

  • 1. The additive effect of vitamin K supplementation and bisphosphonate on fracture risk in post-menopausal osteoporosis: a randomised placebo controlled trial.
    Moore AE; Dulnoan D; Voong K; Ayis S; Mangelis A; Gorska R; Harrington DJ; Tang JCY; Fraser WD; Hampson G
    Arch Osteoporos; 2023 Jun; 18(1):83. PubMed ID: 37338608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.
    Cheung AM; Tile L; Lee Y; Tomlinson G; Hawker G; Scher J; Hu H; Vieth R; Thompson L; Jamal S; Josse R
    PLoS Med; 2008 Oct; 5(10):e196. PubMed ID: 18922041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum vitamin K
    Moore AE; Kim E; Dulnoan D; Dolan AL; Voong K; Ahmad I; Gorska R; Harrington DJ; Hampson G
    Bone; 2020 Dec; 141():115630. PubMed ID: 32919111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.
    Rønn SH; Harsløf T; Oei L; Pedersen SB; Langdahl BL
    Osteoporos Int; 2021 Jan; 32(1):185-191. PubMed ID: 33030563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K to prevent fractures in older women: systematic review and economic evaluation.
    Stevenson M; Lloyd-Jones M; Papaioannou D
    Health Technol Assess; 2009 Sep; 13(45):iii-xi, 1-134. PubMed ID: 19818211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates.
    Cosman F; Gilchrist N; McClung M; Foldes J; de Villiers T; Santora A; Leung A; Samanta S; Heyden N; McGinnis JP; Rosenberg E; Denker AE
    Osteoporos Int; 2016 Jan; 27(1):377-86. PubMed ID: 26556736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age.
    Braam LA; Knapen MH; Geusens P; Brouns F; Hamulyák K; Gerichhausen MJ; Vermeer C
    Calcif Tissue Int; 2003 Jul; 73(1):21-6. PubMed ID: 14506950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of vitamin D in relation to bone health.
    Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
    Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.
    Deane A; Constancio L; Fogelman I; Hampson G
    BMC Musculoskelet Disord; 2007 Jan; 8():3. PubMed ID: 17214897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E
    Osteoporos Int; 2013 Sep; 24(9):2499-507. PubMed ID: 23525894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New spine and non-spine fractures in 871 women/year treated with oral pamidronate plus calcium and vitamin D supplements].
    Man Z; Otero AB
    Medicina (B Aires); 1997; 57 Suppl 1():32-6. PubMed ID: 9567352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women.
    Knapen MH; Schurgers LJ; Vermeer C
    Osteoporos Int; 2007 Jul; 18(7):963-72. PubMed ID: 17287908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial.
    Emaus N; Gjesdal CG; Almås B; Christensen M; Grimsgaard AS; Berntsen GK; Salomonsen L; Fønnebø V
    Osteoporos Int; 2010 Oct; 21(10):1731-40. PubMed ID: 19937427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium plus vitamin D supplementation has limited effects on femoral geometric strength in older postmenopausal women: the Women's Health Initiative.
    Jackson RD; Wright NC; Beck TJ; Sherrill D; Cauley JA; Lewis CE; LaCroix AZ; LeBoff MS; Going S; Bassford T; Chen Z
    Calcif Tissue Int; 2011 Mar; 88(3):198-208. PubMed ID: 21253715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis.
    Bolland MJ; Grey A; Avenell A
    Lancet Diabetes Endocrinol; 2018 Nov; 6(11):847-858. PubMed ID: 30293909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for osteoporosis in people with ß-thalassaemia.
    Bhardwaj A; Swe KM; Sinha NK; Osunkwo I
    Cochrane Database Syst Rev; 2016 Mar; 3():CD010429. PubMed ID: 26964506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.
    Avenell A; Mak JC; O'Connell D
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD000227. PubMed ID: 24729336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri- and post-menopause women; a double-blind, randomized, controlled trial.
    Di Daniele N; Carbonelli MG; Candeloro N; Iacopino L; De Lorenzo A; Andreoli A
    Pharmacol Res; 2004 Dec; 50(6):637-41. PubMed ID: 15501704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal response to treatment with teriparatide (TPD) after bisphosphonate in post-menopausal women with osteoporosis and a high prevalence of secondary risk factors in real-life setting of a metabolic bone clinic; effect of age and vitamin D status.
    Mok J; Brown C; Moore AEB; Min SS; Hampson G
    Endocr Res; 2018 Aug; 43(3):195-202. PubMed ID: 29652557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vitamin K in postmenopausal women: mini review.
    Guralp O; Erel CT
    Maturitas; 2014 Mar; 77(3):294-9. PubMed ID: 24342502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.